Irene Becklund, the PAO of $HIMS, sold 2,203 shares of the company on 04-03-2025 for an estimated $63,402. We received data on the trade from a recent SEC filing. This was a sale of approximately 21.6% of their shares of this class of stock. Following this trade, they now own 8,007 shares of this class of $HIMS stock.
$HIMS Insider Trading Activity
$HIMS insiders have traded $HIMS stock on the open market 149 times in the past 6 months. Of those trades, 2 have been purchases and 147 have been sales.
Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:
- ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 43 sales selling 1,227,495 shares for an estimated $40,179,585.
- OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 36 sales selling 628,681 shares for an estimated $16,193,880.
- MELISSA BAIRD (Chief Operating Officer) has made 0 purchases and 24 sales selling 406,122 shares for an estimated $12,410,617.
- SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 12 sales selling 347,221 shares for an estimated $9,915,609.
- MICHAEL CHI (Chief Commercial Officer) has made 0 purchases and 20 sales selling 255,119 shares for an estimated $7,295,704.
- PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 3 sales selling 42,994 shares for an estimated $1,262,996.
- DAVID B WELLS sold 40,000 shares for an estimated $1,199,584
- IRENE BECKLUND (PAO) has made 0 purchases and 8 sales selling 27,023 shares for an estimated $911,655.
- ANJA MANUEL has made 2 purchases buying 5,000 shares for an estimated $132,259 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HIMS Hedge Fund Activity
We have seen 241 institutional investors add shares of $HIMS stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 14,689,018 shares (+95.3%) to their portfolio in Q4 2024, for an estimated $355,180,455
- FARALLON CAPITAL MANAGEMENT LLC added 8,364,000 shares (+64338.5%) to their portfolio in Q4 2024, for an estimated $202,241,520
- BIT CAPITAL GMBH removed 6,151,360 shares (-80.1%) from their portfolio in Q4 2024, for an estimated $148,739,884
- GOLDMAN SACHS GROUP INC added 4,488,389 shares (+425.3%) to their portfolio in Q4 2024, for an estimated $108,529,246
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,145,305 shares (+192.0%) to their portfolio in Q4 2024, for an estimated $100,233,474
- STATE STREET CORP added 3,146,380 shares (+68.0%) to their portfolio in Q4 2024, for an estimated $76,079,468
- ICONIQ CAPITAL, LLC added 2,874,769 shares (+inf%) to their portfolio in Q4 2024, for an estimated $69,511,914
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HIMS Analyst Ratings
Wall Street analysts have issued reports on $HIMS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Sell" rating on 03/06/2025
- Needham issued a "Buy" rating on 02/25/2025
- Canaccord Genuity issued a "Buy" rating on 02/19/2025
- UBS issued a "Underperform" rating on 12/20/2024
- Piper Sandler issued a "Buy" rating on 10/21/2024
- Bank of America Securities issued a "Buy" rating on 10/14/2024
To track analyst ratings and price targets for $HIMS, check out Quiver Quantitative's $HIMS forecast page.
$HIMS Price Targets
Multiple analysts have issued price targets for $HIMS recently. We have seen 6 analysts offer price targets for $HIMS in the last 6 months, with a median target of $25.5.
Here are some recent targets:
- Maria Ripps from Canaccord Genuity set a target price of $38.0 on 12/02/2024
- Korinne Wolfmeyer from Piper Sandler set a target price of $21.0 on 11/05/2024
- Ryan MacDonald from Needham set a target price of $28.0 on 11/05/2024
- Michael Cherny from Leerink Partners set a target price of $26.0 on 10/29/2024
- Michael Cherny from Bank of America Securities set a target price of $25.0 on 10/21/2024
- Jailendra Singh from Truist Financial set a target price of $23.0 on 10/14/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
